DeepUll Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $50M

  • Investors
  • 15

DeepUll General Information

Description

Operator of a biotechnology company intended to offer an early diagnosis of sepsis and therapeutic recommendations. The company uses artificial intelligence to identify the causative infective agent and provide phenotypic antimicrobial susceptibility results, reducing the unnecessary use of antimicrobials and developing a new diagnostic system that will detect pathogens and antibiotic resistance, without a prior cultivation stage, enabling patients to get treated in the early stages of the disease.

Contact Information

Website
www.deepull.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 936
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 936

DeepUll Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DeepUll Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 16-Apr-2025 $50M Completed Pre-Clinical Trials
5. Accelerator/Incubator 21-Feb-2025 Completed Pre-Clinical Trials
4. Debt - General 05-Dec-2022 Completed Pre-Clinical Trials
3. Early Stage VC (Series B) 20-Oct-2022 Completed Pre-Clinical Trials
2. Secondary Transaction - Private 01-Aug-2021 $3.94M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 07-Jul-2020 $3.94M $3.94M Completed Pre-Clinical Trials
To view DeepUll’s complete valuation and funding history, request access »

DeepUll Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
To view DeepUll’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

DeepUll Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 16

    Pending

  • Expiring in next 12 mo

DeepUll Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2978358-B2 Systems and methods for the detection of sepsis and treatment of patients Active 03-Feb-2023
ES-3053557-R1 Systems and methods for the detection of sepsis and treatment of patients Pending 03-Feb-2023
ES-2978358-A1 Systems and methods for the detection of sepsis and treatment of patients (machine-translation by google translate, not legally binding) Active 03-Feb-2023
ES-3053557-A2 Systems and methods for the detection of sepsis and treatment of patients (machine-translation by google translate, not legally binding) Pending 03-Feb-2023
JP-2025505360-A Systems, methods and apparatus for pathogen identification - patents.com Pending 14-Jan-2022 G01N35/1009
To view DeepUll’s complete patent history, request access »

DeepUll Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DeepUll Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Columbus Venture Partners Venture Capital Minority
Medex Partners Venture Capital Minority
Panakes Partners Venture Capital Minority
BCN Health Booster Accelerator/Incubator
Aliath Bioventures Corporation Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

DeepUll FAQs

  • When was DeepUll founded?

    DeepUll was founded in 2019.

  • Where is DeepUll headquartered?

    DeepUll is headquartered in Barcelona, Spain.

  • What is the size of DeepUll?

    DeepUll has 41 total employees.

  • What industry is DeepUll in?

    DeepUll’s primary industry is Biotechnology.

  • Is DeepUll a private or public company?

    DeepUll is a Private company.

  • What is DeepUll’s current revenue?

    The current revenue for DeepUll is .

  • How much funding has DeepUll raised over time?

    DeepUll has raised $91.3M.

  • Who are DeepUll’s investors?

    Columbus Venture Partners, Medex Partners, Panakes Partners, BCN Health Booster, and Aliath Bioventures are 5 of 15 investors who have invested in DeepUll.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process